Trial Profile
A prospective, open-label, multicenter study of perampanel as add-on treatment in patients with refractory epilepsies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 17 Feb 2017 New trial record